Anthony Gaspari, MD
Dermatology · Baltimore, MDNPI 1881635522
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,325 of the $7,466 with a category attached, or 84.7%. AbbVie accounts for 85.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $6,410 and has fallen 95.5% since, to $289 in 2025.
Across 37 payments — averaging $201.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Johnson & Johnson$203
- Regeneron Healthcare Solutions, Inc.$125
- Lilly USA, LLC$125
- Novartis$98
- Dermavant Sciences, Inc.$78
- plus $436 from 11 others
Across 23 payments — averaging $2564.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$32K
- Galderma Research & Development, LLC$17K
- Regeneron$5K
- Galderma Laboratories, L.p.$5K
What the payments were for
- Consulting fees$6,32585%
- Food & beverage$1,04114%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $6,401 |
| Johnson & Johnson | 5 | $203 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Novartis | 5 | $98 |
| Dermavant Sciences, Inc. | 1 | $78 |
| Sun Pharmaceutical Industries Inc. | 3 | $63 |
| UCB, Inc. | 3 | $56 |
| Genentech USA, Inc. | 2 | $56 |
| Incyte Corporation | 2 | $54 |
| Amgen | 2 | $51 |
| Pfizer | 2 | $37 |
| Boehringer Ingelheim | 1 | $30 |
| Kerecis Limited | 1 | $30 |
| Kyowa Kirin, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Almirall LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,466 in reported general payments places this provider in the 75th percentile of 306 dermatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $271,893 |
| Taltz AutoinjectorIxekizumab | 22 | $188,875 |
| Dupixent PenDupilumab | 21 | $107,488 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $87,004 |
| Ketoconazole | 131 | $6,132 |
| Fluocinonide | 61 | $2,895 |
| Clobetasol Propionate | 58 | $2,574 |
| Triamcinolone Acetonide | 233 | $2,573 |
| Fluorouracil | 34 | $2,499 |
| Doxycycline Hyclate | 56 | $2,368 |
| Metronidazole | 38 | $1,866 |
| Clindamycin Phosphate | 34 | $1,619 |
| ValacyclovirValacyclovir Hcl | 40 | $829 |
| Betamethasone Valerate | 12 | $381 |
| Ammonium Lactate | 12 | $377 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Baltimore
- Shawn KwatraBaltimore$1.1M
- Crystal AguhBaltimore$142K
- Tamia Harris-TryonBaltimore$128K
- Elizabeth TanziBaltimore$59K
- Luis GarzaBaltimore$44K
- Sewon KangBaltimore$44K
- Sima RozatiBaltimore$35K
- Larry GastonBaltimore$27K
- Janet LinBaltimore$23K
- Julie DeutschBaltimore$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.